Arachidonyl trifluoromethyl ketone is neuroprotective after spinal cord injury

Journal of Neurotrauma

Volumn 26, Issue 8, 2009, Pages 1429-1434

  Huang, Wenlong ^a   Bhavsar, Amar ^a   Ward, Rachael E ^a   Hall, Jodie C E ^a   Priestley, John V ^a   Michael Titus, Adina T ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

cPLA2; Inhibition; Neuroprotection; Rat; Secondary injury; Spinal cord compression

Indexed keywords

ARACHIDONYL TRIFLUOROMETHYL KETONE; CYTOSOLIC PHOSPHOLIPASE A2; ARACHIDONIC ACID DERIVATIVE; ARACHIDONYLTRIFLUOROMETHANE; NEUROPROTECTIVE AGENT;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; FEMALE; LOCOMOTION; NEUROPROTECTION; NONHUMAN; RAT; SCORING SYSTEM; SPINAL CORD COMPRESSION; SPINAL CORD INJURY; ANALYSIS OF VARIANCE; ANIMAL; CELL COUNT; CELL SURVIVAL; CONVALESCENCE; DRUG EFFECTS; IMMUNOHISTOCHEMISTRY; MACROPHAGE; METABOLISM; MOTOR ACTIVITY; NERVE CELL; OLIGODENDROGLIA; PATHOLOGY; SPRAGUE DAWLEY RAT;

ANALYSIS OF VARIANCE; ANIMALS; ARACHIDONIC ACIDS; CELL COUNT; CELL SURVIVAL; IMMUNOHISTOCHEMISTRY; MACROPHAGES; MOTOR ACTIVITY; NEURONS; NEUROPROTECTIVE AGENTS; OLIGODENDROGLIA; RATS; RATS, SPRAGUE-DAWLEY; RECOVERY OF FUNCTION; SPINAL CORD COMPRESSION;

EID: 68349106700     PISSN: 08977151     EISSN: None     Source Type: Journal    
DOI: 10.1089/neu.2008.0835     Document Type: Article

References (41)

1. 2 by bromoenol lacatone and trifluoro methyl ketones. J. Biol. Chem. 270, 445-450.
2. 2. Biochim. Biophys. Acta. 1259, 125-136.
3. Amar, A.P., and Levy, M.L. (1999). Pathogenesis and pharma-cological strategies for mitigating secondary damage in acute spinal cord injury. Neurosurgery 44, 1027-1040.
4. Basso, D.M., Beattie, M.S., and Bresnahan, J.C. (1996). Graded histological and locomotor outcomes after spinal cord contusion using the NYU weight-drop device versus transection. Exp. Neurol. 139, 244-256.
5. Bazan, N.G. Jr. (1970). Effects of ischemia and electroconvulsive shock on free fatty acid pool in the brain. Biochim. Biophys. Acta. 218, 1-10.
6. Demediuk, P., Saunders, R.D., Anderson, D.K., Means, E.D., and Horrocks, L.A. (1985). Membrane lipid changes in laminectomised and traumatized cat spinal cord. Proc. Natl. Acad. Sci. U.S.A. 82, 7071-7075.
7. Dennis, E.A. (1997). The growing phospholipase A2 superfamily of signal transduction enzymes. Trends. Biochem. Sci. 22, 1-2.
8. 2 activity: their neuropharmacological effects and therapeutical importance for the treatment of neurologic disorders. Pharmacol. Rev. 58, 591-620.
9. Farooqui, A.A., Taylor, W.A., and Horrocks, L.A. (1987). Phospholipases, lysophospholipases, and lipases and their involvement in various diseases. Neurochem. Pathol. 7, 99-128.
10. Ghomashchi, F., Loo, R., Balsinde, J., Bartoli, F., Apitz-Castro, R., Clark, J.D., Dennis, E.A., and Gelb, M.H. (1999). Tri-fluoromethyl ketones and methyl fluorophosphonates as inhibitors of group IV and VI phospholipases A(2): structure-function studies with vesicle, micelle, and membrane assays. Biochim. Biophys. Acta. 1420, 45-56.
11. Hall, E.D., and Springer, J.E. (2004). Neuroprotection and acute spinal cord injury: a reappraisal. NeuroRx. 1, 80-100. (Pubitemid 46589342)
12. Horrocks, L.A., Demediuk, P., Saunders, R.D., Dugan, L., Clendenon, N.R., Means, E.D., and Anderson, D.K. (1985). The degradation of phospholipids, formation of metabolites of arachidonic acid, and demyelination following experimental spinal cord injury. Cent. Nerv. Syst. Trauma 2, 115-120.
13. Huang, W.L., George, K.J., Ibba, V., Liu, M.C., Averill, S., Quartu, M., Hamlyn, P.J., and Priestley, J.V. (2007). The characteristics of neuronal injury in a static compression model of spinal cord injury in adult rats. Eur. J. Neurosci. 25, 362-372.
14. 2 plays a key role in the pathogenesis of multiple sclerosis-like disease. Neuron 41, 323-335.
15. Kaptanoglu, E., Okutan, O., Akbiyik, F., Solaroglu, I., Kilinc, A., and Beskonakli, E. (2004).Correlation of injury severity and tissue Evans blue content, lipid peroxidation and clinical evaluation in acute spinal cord injury in rats. J. Clin. Neurosci. 11, 879-885.
16. 2 in brain cortical cultures. Biochem. J. 310 (Pt. 1), 83-90.
17. 2 messenger RNA mainly in neurons in the rat brain. Neuroscience 92, 1061-1077.
18. 2) and lipid mediator release in the brain. J. Lipid. Mediat. Cell Signal 14, 3-7.
19. Liu, D., Liu, J., and Wen, J. (1999). Elevation of hydrogen peroxide after spinal cord injury detected by using the Fenton reaction. Free. Radic. Biol. Med. 27, 478-482.
20. 2 in mediating spinal cord secondary injury. Ann. Neurol. 59, 606-619.
21. Lopez-Vales, R., Ghasemlou, N., and Kerr, B.J. (2007). Neuroscience Meeting Planner. San Diego, CA: Society for Neuroscience. Online. Program No. 600.20.
22. 2 by arachidonyl tri-fluoromethylketone prevents chronic inflammation in mice. Eur. J. Pharmacol. 539, 195-204.
23. 2 are expressed in rat brain. Neurosci. Lett. 258, 139-142.
24. Murakami, M., Nakatani, Y., Atsumi, G., Inoue, K., and Kudo, I. (1997). Regulatory functions of phospholipase A2. Crit. Rev. Immunol. 17, 225-283.
25. Murphy, E.J., Behrmann, D., Bates, C.M., and Horrocks, L.A. (1994). Lipid alterations following impact spinal cord injury in the rat. Mol. Chem. Neuropathol. 23, 13-26.
26. 2 inhibition. Nat. Immunol. 2, 145-149.
27. 2, arachidonyl trifluoromethylketone, attenuates LPS-induced lung injury in mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 284, 720-726.
28. Nystrom, B., Berglund, J.E., and Bergquist, E. (1988). Methodological analysis of an experimental spinal cord compression model in the rat. Acta. Neurol. Scand. 78, 460-466.
29. 2 in rat and monkey spinal cord. J. Mol. Neurosci. 12, 123-130.
30. Ousman, S.S., and David, S. (2000). Lysophosphatidylcholine induces rapid recruitment and activation of macrophages in the adult mouse spinal cord. Glia 30, 92-104.
31. Phillis, J.W., and O'Regan, M.H. (2004). A potentially critical role of phospholipases in central nervous systemischemic, traumatic, and neurodegenerative disorders. Brain Res. Rev. 44, 13-47.
32. 2, blocks production of arachidonate and 12-hydroxytetraenoic acid by calcium ionophore-challenged platelets. J. Biol. Chem. 269, 15619-15624.
33. Rordorf, G., Uemura, Y., and Bonventre, J.V. (1991). Characterization of phospholipase A2 (PLA2) activity in gerbil brain: enhanced activities of cytosolic, mitochondrial, and microsomal forms after ischemia and reperfusion. J. Neurosci. 11, 1829-1836.
34. 2 knockout mouse. J. Lipid Res. 44, 109-117.
35. Schapira, A.H.V. (1996). Oxidative stress and mitochondrial dysfunction in neurodegeneration. Curr. Opin. Neurol. 9, 260-264.
36. 2 is activated after experimental closed head injury in the rat. J. Neurochem. 53, 1541-1546.
37. 2. Biochemistry 32, 5935-5940.
38. 2 in Her14 fibroblasts by hydrogen peroxide: a p42/44(MAPK)- dependent and phosphorylation-independent mechanism. Biochim. Biophys. Acta. 1636, 183-195.
39. Volterra, A., Trotti, D., Tromba, C., Floridi, S., and Racagni, G. (1994). Glutamate uptake inhibition by oxygen free radicals in rat cortical astrocytes. J. Neurosci. 14, 2924-2932. (Pubitemid 24140915)
40. Wolfe, L.S., and Horrocks, L.A. (1994). Eicosanoids. Raven Press: New York.
41. Xu, W., Chi, L., Xu, R., Ke, Y., Luo, C., Cai, J., Qiu, M., Gozal, D., and Liu, R. (2005). Increased production of reactive oxygen species contributes to motor neuron death in a compression mouse model of spinal cord injury. Spinal Cord 43, 204-213.